The impact of UV360 on the locomotor activity of zebrafish larvae. by Lihan Xu (18778257)

The relationship between pre-peak shear stiffness and <i>JRC</i>, normal stress. by Zhezhe Zhang (19704587)

The outcomes of transcriptome analyses. by Lihan Xu (18778257)

Fig 10 - by Zhezhe Zhang (19704587)

Fig 19 - by Zhezhe Zhang (19704587)

Fig 8 - by Zhezhe Zhang (19704587)

Fig 20 - by Zhezhe Zhang (19704587)

The impact of UV360 on the viability and developmental progression of zebrafish embryos. by Lihan Xu (18778257)

The impact of UV360 on the neurophysiological activity of zebrafish larvae. by Lihan Xu (18778257)

Fig 26 - by Zhezhe Zhang (19704587)

Fig 5 - by Zhezhe Zhang (19704587)

(A) PCA score scatter plots; (B)Heat map visualization of detected metabolites in PD and D phases; Various colors in the figure represent the relative content. by Bingshuo Shi (21485387)

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

PLE inhibits IMQ-induced inflammatory in mice, and the contents of TNF-α (A) and IL-17A (B). by Xiaoqiang Huang (1457860)

Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Study selection criteria. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PRISMA flow chart. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

GRADE judgements. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

Basic characteristics of the included studies. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”